The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Soloxine 0.3 mg Tablet

0.3 mg/tablet Tablet

Virbac S.A.VPA10988/069/003

Main Information

Trade NameSoloxine 0.3 mg Tablet
Active SubstancesLevothyroxine sodium
Strength0.3 mg/tablet
Dosage FormTablet
Licence HolderVirbac S.A.
Licence NumberVPA10988/069/003

Group Information

ATC CodeQH03AA01 levothyroxine sodium
Therapeutic ClassHormone


Licence Issued19/01/2007
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back